SIMCERE PHARMA(02096.HK) will spend HKD 22.21 million to repurchase 1.88 million shares on Jan 20, 2026
SIMCERE PHARMA(02096.HK) released an announcement on Jan 20, 2026, stating that on Jan 20, 2026 it will spend HKD 22.21 million to repurchase 1.88 million shares, repurchase price per share is HKD 11.5945 - HKD 11.9046.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- SIMCERE PHARMA (02096.HK): SIM0712 Cleared for Atopic Dermatitis Trial
- SIMCERE PHARMA (02096.HK): Sublingual Stroke Drug Added to 2026 National Reimbursement List
- SIMCERE PHARMA (02096.HK): SIM0725 Cleared for Clinical Trial in Autoimmune Diseases
- SIMCERE PHARMA (02096.HK): SIM0709 trial cleared in Germany
- SIMCERE PHARMA (02096.HK): zemprocitinib RA NDA accepted by NMPA